1887

Abstract

Novel real-time PCR assays targeting the insertion sequence IS, the toxin promoter region and insertion sequence IS were designed. PCR assays were capable of detecting ≤10 copies of target DNA per reaction, with an amplification efficiency of ≥90 %. From September 2003 to December 2009, per-nasal swabs and nasopharyngeal aspirates submitted for culture from patients ≤1 month to >15 years of age were examined by real-time PCR. Among 1324 patients, 76 (5.7 %) were culture positive and 145 (10.95 %) were PCR positive. Of the PCR-positive patients, 117 (81 %) were aged 6 months or less. A total of 1548 samples were examined, of which 87 (5.6 %) were culture positive for and 169 (10.92 %) were PCR positive. All culture-positive samples were PCR positive. Seven specimens (0.5 %) were culture positive and 10 (0.8 %) were PCR positive, with all culture-positive samples yielding PCR-positive results. A review of patient laboratory records showed that of the 1324 patients tested for pertussis 555 (42 %) had samples referred for respiratory syncytial virus (RSV) testing and 165 (30 %) were positive, as compared to 19.4 % of the total 5719 patients tested for RSV in this period. Analysis of the age distribution of RSV-positive patients identified that 129 (78 %) were aged 6 months or less, similar to the incidence observed for pertussis in that patient age group. In conclusion, the introduction of the real-time PCR assays for the routine detection of resulted in a 91 % increase in the detection of the organism as compared to microbiological culture. The incidence of infection with is low while the incidence of RSV infection in infants suspected of having pertussis is high, with a similar age distribution to infection.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.030049-0
2011-06-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/60/6/722.html?itemId=/content/journal/jmm/10.1099/jmm.0.030049-0&mimeType=html&fmt=ahah

References

  1. André P., Caro V., Njamkepo E., Wendelboe A. M., Van Rie A., Guiso N. 2008; Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007. J Clin Microbiol 46:1672–1677 [View Article][PubMed]
    [Google Scholar]
  2. Antila M., He Q., de Jong C., Aarts I., Verbakel H., Bruisten S., Keller S., Haanperä M., Mäkinen J. et al. 2006; Bordetella holmesii DNA is not detected in nasopharyngeal swabs from Finnish and Dutch patients with suspected pertussis. J Med Microbiol 55:1043–1051 [View Article][PubMed]
    [Google Scholar]
  3. Celentano L. P., Massari M., Paramatti D., Salmaso S., Tozzi A. E.EUVAC-NET Group 2005; Resurgence of pertussis in Europe. Pediatr Infect Dis J 24:761–765 [View Article][PubMed]
    [Google Scholar]
  4. Chan E. L., Antonishyn N., McDonald R., Maksymiw T., Pieroni P., Nagle E., Horsman G. B. 2002; The use of TaqMan PCR assay for detection of Bordetella pertussis infection from clinical specimens. Arch Pathol Lab Med 126:173–176[PubMed]
    [Google Scholar]
  5. Cherry J. D. 2005; The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 115:1422–1427 [View Article][PubMed]
    [Google Scholar]
  6. Cosnes-Lambe C., Raymond J., Chalumeau M., Pons-Catalano C., Moulin F., de Suremain N., Reglier-Poupet H., Lebon P., Poyart C., Gendrel D. 2008; Pertussis and respiratory syncytial virus infections. Eur J Pediatr 167:1017–1019 [View Article][PubMed]
    [Google Scholar]
  7. de Melker H. E., Versteegh F. G. A., Conyn-van Spaendonck M. A. E., Elvers L. H., Berbers G. A. M., van der Zee A., Schellekens J. F. P. 2000; Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 38:800–806[PubMed]
    [Google Scholar]
  8. Fry N. K., Duncan J., Wagner K., Tzivra O., Doshi N., Litt D. J., Crowcroft N., Miller E., George R. C., Harrison T. G. 2009; Role of PCR in the diagnosis of pertussis infection in infants: 5 years’ experience of provision of a same-day real-time PCR service in England and Wales from 2002 to 2007. J Med Microbiol 58:1023–1029 [View Article][PubMed]
    [Google Scholar]
  9. Guiso N., Berbers G., Fry N. K., He Q., Riffelmann M., Wirsing von König C. H.EU Pertstrain Group 2011; What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis 30:307–312 [View Article][PubMed]
    [Google Scholar]
  10. Halperin S. A. 2005; Pertussis – a disease and vaccine for all ages. N Engl J Med 353:1615–1617 [View Article][PubMed]
    [Google Scholar]
  11. Korppi M., Hiltunen J. 2007; Pertussis is common in nonvaccinated infants hospitalized for respiratory syncytial virus infection. Pediatr Infect Dis J 26:316–318 [View Article][PubMed]
    [Google Scholar]
  12. Kösters K., Riffelmann M., Wirsing von König C. H. 2001; Evaluation of a real-time PCR assay for detection of Bordetella pertussis and B. parapertussis in clinical samples. J Med Microbiol 50:436–440[PubMed]
    [Google Scholar]
  13. Lievano F. A., Reynolds M. A., Waring A. L., Ackelsberg J., Bisgard K. M., Sanden G. N., Guris D., Golaz A., Bopp D. J. et al. 2002; Issues associated with and recommendations for using PCR to detect outbreaks of pertussis. J Clin Microbiol 40:2801–2805 [View Article][PubMed]
    [Google Scholar]
  14. Mattoo S., Cherry J. D. 2005; Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18:326–382 [View Article][PubMed]
    [Google Scholar]
  15. Mazengia E., Silva E. A., Peppe J. A., Timperi R., George H. 2000; Recovery of Bordetella holmesii from patients with pertussis-like symptoms: use of pulsed-field gel electrophoresis to characterize circulating strains. J Clin Microbiol 38:2330–2333[PubMed]
    [Google Scholar]
  16. Meade B. D., Bollen A. 1994; Recommendations for use of the polymerase chain reaction in the diagnosis of Bordetella pertussis infections. J Med Microbiol 41:51–55 [View Article][PubMed]
    [Google Scholar]
  17. Mohammadi T., Pietersz R. N., Vandenbroucke-Grauls C. M., Savelkoul P. H., Reesink H. W. 2005; Detection of bacteria in platelet concentrates: comparison of broad-range real-time 16S rDNA polymerase chain reaction and automated culturing. Transfusion 45:731–736 [View Article][PubMed]
    [Google Scholar]
  18. Mooi F. R., van Loo I. H. M., van Gent M., He Q., Bart M. J., Heuvelman K. J., de Greeff S. C., Diavatopoulos D., Teunis P. et al. 2009; Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 15:1206–1213 [View Article][PubMed]
    [Google Scholar]
  19. Muyldermans G., Soetens O., Antoine M., Bruisten S., Vincart B., Doucet-Populaire F., Fry N. K., Olcén P., Scheftel J. M. et al. 2005; External quality assessment for molecular detection of Bordetella pertussis in European laboratories. J Clin Microbiol 43:30–35 [View Article][PubMed]
    [Google Scholar]
  20. Parton R. 2005; Bordetella. In Topley & Wilson’s Microbiology and Microbial Infections pp. 1786–1817 Edited by Borriello S. P., Murray P. R., Funke G. London: Edward Arnold;
    [Google Scholar]
  21. Plotkin S. 2005; The global pertussis initiative: process overview. Pediatr Infect Dis J 24:Suppl.S7–S9 [View Article][PubMed]
    [Google Scholar]
  22. Reischl U., Lehn N., Sanden G. N., Loeffelholz M. J. 2001; Real-time PCR assay targeting IS481 of Bordetella pertussis and molecular basis for detecting Bordetella holmesii. J Clin Microbiol 39:1963–1966 [View Article][PubMed]
    [Google Scholar]
  23. Riffelmann M., Wirsing von König C. H., Caro V., Guiso N.Pertussis PCR Consensus Group 2005; Nucleic acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol 43:4925–4929 [View Article][PubMed]
    [Google Scholar]
  24. Riffelmann M., Littmann M., Hülße C., Hellenbrand W., Wirsing von König C. H. 2008; Pertussis: not only a disease of childhood. Dtsch Arztebl Int 105:623–628[PubMed]
    [Google Scholar]
  25. Sawal M., Cohen M., Irazuzta J. E., Kumar R., Kirton C., Brundler M.-A., Evans C. A., Wilson J. A., Raffeeq P. et al. 2009; Fulminant pertussis: a multi-center study with new insights into the clinico-pathological mechanisms. Pediatr Pulmonol 44:970–980 [View Article][PubMed]
    [Google Scholar]
  26. Shahdadpuri R. I., Nicholson A. J., Bedford D., O’Flanagan D. 2004; Pertussis – going, going, but not gone: thirteen year trends in the incidence of pertussis in the Republic of Ireland and North Eastern Health Board. Ir Med J 97:44–46[PubMed]
    [Google Scholar]
  27. Stehr K., Cherry J. D., Heininger U., Schmitt-Grohé S., Überall M., Laussucq S., Eckhardt T., Meyer M., Engelhardt R. et al. 1998; A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics 101:1–11 [View Article][PubMed]
    [Google Scholar]
  28. van Woensel J. B. M., van Aalderen W. M. C., Kimpen J. L. L. 2003; Viral lower respiratory tract infection in infants and young children. BMJ 327:36–40 [View Article][PubMed]
    [Google Scholar]
  29. Walsh P., Overmeyer C., Kimmel L., Feola M., Pusavat J., Nguyen T. A., Kuan S., Emery K., Rosengreen M. et al. 2008; Prevalence of Bordetella pertussis and Bordetella parapertussis in samples submitted for RSV screening. West J Emerg Med 9:135–140[PubMed]
    [Google Scholar]
  30. Ward J. I., Cherry J. D., Chang S. J., Partridge S., Lee H., Treanor J., Greenberg D. P., Keitel W., Barenkamp S. et al. 2005; Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 353:1555–1563 [View Article][PubMed]
    [Google Scholar]
  31. Wirsing von König C. H., Halperin S., Riffelmann M., Guiso N. 2002; Pertussis of adults and infants. Lancet Infect Dis 2:744–750 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.030049-0
Loading
/content/journal/jmm/10.1099/jmm.0.030049-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error